124 related articles for article (PubMed ID: 16417228)
1. Local expression of indoleamine 2,3-dioxygenase protects engraftment of xenogeneic skin substitute.
Li Y; Tredget EE; Ghaffari A; Lin X; Kilani RT; Ghahary A
J Invest Dermatol; 2006 Jan; 126(1):128-36. PubMed ID: 16417228
[TBL] [Abstract][Full Text] [Related]
2. Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute.
Forouzandeh F; Jalili RB; Hartwell RV; Allan SE; Boyce S; Supp D; Ghahary A
Wound Repair Regen; 2010; 18(6):614-23. PubMed ID: 20955343
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
4. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
5. Immunoprotective role of indoleamine 2,3-dioxygenase in engraftment of allogenic skin substitute in wound healing.
Bahar MA; Nabai L; Ghahary A
J Burn Care Res; 2012; 33(3):364-70. PubMed ID: 22249100
[TBL] [Abstract][Full Text] [Related]
6. Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.
Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
Wound Repair Regen; 2008; 16(3):379-87. PubMed ID: 18471256
[TBL] [Abstract][Full Text] [Related]
7. Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses.
Poormasjedi-Meibod MS; Jalili RB; Hosseini-Tabatabaei A; Hartwell R; Ghahary A
PLoS One; 2013; 8(8):e71044. PubMed ID: 23940687
[TBL] [Abstract][Full Text] [Related]
8. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Habibi D; Jalili RB; Forouzandeh F; Ong CJ; Ghahary A
J Cell Physiol; 2010 Oct; 225(1):196-205. PubMed ID: 20648630
[TBL] [Abstract][Full Text] [Related]
9. Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Uludag H; Kilani RT; Karami A; Li Y; Iwashina T; Ghahary A
J Cell Physiol; 2004 Oct; 201(1):146-54. PubMed ID: 15281097
[TBL] [Abstract][Full Text] [Related]
10. An in-situ forming skin substitute improves healing outcome in a hypertrophic scar model.
Hartwell R; Poormasjedi-Meibod MS; Chavez-Munoz C; Jalili RB; Hossenini-Tabatabaei A; Ghahary A
Tissue Eng Part A; 2015 Mar; 21(5-6):1085-94. PubMed ID: 25412924
[TBL] [Abstract][Full Text] [Related]
11. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor.
Ghahary A; Li Y; Tredget EE; Kilani RT; Iwashina T; Karami A; Lin X
J Invest Dermatol; 2004 Apr; 122(4):953-64. PubMed ID: 15102086
[TBL] [Abstract][Full Text] [Related]
12. Cell surface expression of MHC class I antigen is suppressed in indoleamine 2,3-dioxygenase genetically modified keratinocytes: implications in allogeneic skin substitute engraftment.
Li Y; Tredget EE; Ghahary A
Hum Immunol; 2004 Feb; 65(2):114-23. PubMed ID: 14969766
[TBL] [Abstract][Full Text] [Related]
13. Mouse pancreatic islets are resistant to indoleamine 2,3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function.
Jalili RB; Forouzandeh F; Moeenrezakhanlou A; Rayat GR; Rajotte RV; Uludag H; Ghahary A
Am J Pathol; 2009 Jan; 174(1):196-205. PubMed ID: 19074614
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of indoleamine dioxygenase in rat liver allografts using a high-efficiency adeno-associated virus vector does not prevent acute rejection.
Laurence JM; Wang C; Zheng M; Cunningham S; Earl J; Tay SS; Allen RD; McCaughan GW; Alexander IE; Bishop GA; Sharland AF
Liver Transpl; 2009 Feb; 15(2):233-41. PubMed ID: 19177450
[TBL] [Abstract][Full Text] [Related]
15. Suppression of islet allogeneic immune response by indoleamine 2,3 dioxygenase-expressing fibroblasts.
Jalili RB; Rayat GR; Rajotte RV; Ghahary A
J Cell Physiol; 2007 Oct; 213(1):137-43. PubMed ID: 17477384
[TBL] [Abstract][Full Text] [Related]
16. Immunological role of indoleamine 2,3-dioxygenase in rat liver allograft rejection and tolerance.
Lin YC; Chen CL; Nakano T; Goto S; Kao YH; Hsu LW; Lai CY; Jawan B; Cheng YF; Tateno C; Yoshizato K
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e243-50. PubMed ID: 17645734
[TBL] [Abstract][Full Text] [Related]
17. Prolonged skin grafts survival time by IFN-γ in allogeneic skin transplantation model during acute rejection through IFN-γ/STAT3/IDO pathway in epidermal layer.
Zhang Y; Wang Y; Wu G; Zhang W; Wang X; Cai W; Zhang J; Han S; Li Y; Bai X; Shi J; Su L; Hu D
Biochem Biophys Res Commun; 2018 Feb; 496(2):436-442. PubMed ID: 29288671
[TBL] [Abstract][Full Text] [Related]
18. Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model.
Chavez-Munoz C; Hartwell R; Jalili RB; Carr M; Kilani RT; Jafarnejad SM; Rahmani-Neishabour E; Forouzandeh F; Boyce ST; Ghahary A
J Invest Dermatol; 2012 May; 132(5):1501-5. PubMed ID: 22297642
[No Abstract] [Full Text] [Related]
19. Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing.
Ito H; Ando T; Ogiso H; Arioka Y; Saito K; Seishima M
Biomaterials; 2015 Jun; 53():221-8. PubMed ID: 25890721
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal injection of IDO-expressing dermal fibroblasts improves the allograft survival.
Khosravi-Maharlooei M; Pakyari M; Jalili RB; Kilani RT; Ghahary A
Clin Immunol; 2017 Jan; 174():1-9. PubMed ID: 27989895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
